STIVARGA Promotional Presentation
Loading Map....
Therapy for Patients with Previously Treated Metastatic Colorectal Cancer (mCRC): Your Patient’s Journey
Presenter:Tim Freitas, MS, RN
Join your colleagues to learn more about:
- Current National Comprehensive Cancer Network Clinical Practice Guidelines (NCCN Guidelines®) describing therapies for patients with mCRC
- How STIVARGA works as an oral inhibitor of multiple kinases
- The clinical trial results of STIVARGA for previously treated patients with mCRC
- Dosing strategies for certain treatment-emergent adverse events, including dose modifications and temporary or permanent discontinuations
- Bayer’s support programs including financial and nursing services for offices and patients
If you’d like to attend, please RSVP at www.myprogramrsvp.com